Galaxy Therapeutics announced it has completed enrollment in the SEAL IT pivotal trial evaluating the company’s saccular ...
CorMedix Therapeutics announced interim results for the company’s ongoing real-world study of its DefenCath (taurolidine ...
The American College of Cardiology (ACC) announced that a new scientific statement on the management of peripheral artery dise ...
Shape Memory Medical Inc. announced that its Impede embolization plug product family, which previously received CE Mark approv ...
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback